Terms of Use for the Research Library

Everything Remy Peptides publishes is reference material about compounds intended exclusively for in-vitro laboratory research and scientific investigation by qualified professionals. The compounds discussed are not for human consumption, veterinary use, or any clinical application.

By using this website you confirm that you understand and accept this limitation and that any work you undertake with the compounds discussed here will be for lawful research purposes only. Remy Peptides applies this wording across every research page, calculator, and batch record.

This library is written for:

• Readers aged 21 or older
• Qualified research professionals, scientists, or people affiliated with a research institution
• Readers seeking laboratory-context reference material, not medical or veterinary guidance

If you are looking for treatment information, consult a licensed healthcare professional. Nothing on this site is a substitute for medical advice.

Remy Peptides is an independent research-information publisher. It does not sell, supply, distribute, or broker peptides or any other product, and it does not accept orders, take payment, or arrange shipment of research materials.

No page on this site constitutes an offer, a quotation, or an invitation to treat. If you encounter a site, account, or message claiming to transact on our behalf, treat it as unaffiliated and check the verified channels listed on our contact verification page.

The Certificates of Analysis published in the COA library and mirrored in the lab results archive are historical third-party analytical records. They document specific batches as tested on specific dates by Janoshik Analytical and are kept online, unaltered, so that purity figures cited elsewhere on this site remain checkable against their source documents.

They are not a representation about any material you may hold. A certificate describes only the batch and sample it names.

Remy Peptides endeavours to publish accurate compound descriptions, specifications, and certificates of analysis (COA). However, we do not warrant that all information on this website is complete, current, or error-free. Trial data, approval status, and regulatory framing change over time.

Third-party laboratory testing is conducted independently. Test results reflect the specific batch tested at the time of analysis. The flagship archived Retatrutide 30mg pen record is batch RETP002, tested by Janoshik Analytical at 99.262% HPLC purity, and described on-site as a 300-click research pen at 0.1mg per click.

Where any page conflicts with a published COA, the COA and its batch-specific documentation control until the page is corrected. Corrections can be reported to info@remypeptides.com.

Remy Peptides shall not be held liable for any direct, indirect, incidental, or consequential damages arising from reliance on information published on this website.

Readers assume full responsibility for compliance with all applicable local, national, and international laws and regulations regarding the possession and use of research compounds in their own jurisdiction.

All content on this website — including text, graphics, logos, images, and design — is the property of Remy Peptides and is protected by applicable intellectual property laws. Reproduction, distribution, or modification without prior written consent is prohibited.

These terms are governed by and construed in accordance with the laws of the United Arab Emirates. Any disputes arising from or related to these terms shall be subject to the exclusive jurisdiction of the courts of the UAE.

Remy Peptides reserves the right to update these Terms of Use at any time. Changes take effect upon posting to this page. Continued use of the website constitutes acceptance of the revised terms.